InMode (INMD) Net Income towards Common Stockholders (2018 - 2026)
InMode's (INMD) quarterly Net Income towards Common Stockholders came in at $11.6 million in Q1 2026, down 36.48% year-on-year from $18.2 million in Q1 2025, and down 67.49% quarter-over-quarter from $35.6 million in Q4 2025.
InMode (INMD) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
InMode has disclosed Net Income towards Common Stockholders across 9 years of filings, most recently posting $11.6 million for Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at $11.6 million, down 36.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $95.7 million (up 28.22% YoY), and the FY2025 annual result was $126.8 million, up 20.03% from the prior year.
- Net Income towards Common Stockholders came in at $11.6 million for Q1 2026 at InMode, down from $35.6 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $65.2 million in Q4 2023 to a low of -$18.4 million in Q4 2024.
- The 5-year median for Net Income towards Common Stockholders is $35.6 million (2025), against an average of $33.5 million.
- Across the five-year window, Net Income towards Common Stockholders sank 128.16% in 2024 and surged 293.77% in 2025, its largest moves.
- InMode's Net Income towards Common Stockholders stood at $37.7 million in 2022, then surged by 72.81% to $65.2 million in 2023, then plunged by 128.16% to -$18.4 million in 2024, then soared by 293.77% to $35.6 million in 2025, then plunged by 67.49% to $11.6 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $11.6 million (Q1 2026), $35.6 million (Q4 2025), and $21.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | InMode | 3.36 | -388.37 Mn | 61.55 Mn | 11.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.56 Mn |
| Dec 31, 2025 | 35.56 Mn |
| Sep 30, 2025 | 21.86 Mn |
| Jun 30, 2025 | 26.74 Mn |
| Mar 31, 2025 | 18.20 Mn |
| Dec 31, 2024 | -18.35 Mn |
| Sep 30, 2024 | 50.99 Mn |
| Jun 30, 2024 | 23.82 Mn |
| Mar 31, 2024 | 23.70 Mn |
| Dec 31, 2023 | 65.16 Mn |
| Sep 30, 2023 | 46.52 Mn |
| Jun 30, 2023 | 62.23 Mn |
| Mar 31, 2023 | 40.51 Mn |
| Dec 31, 2022 | 37.71 Mn |
| Sep 30, 2022 | 48.79 Mn |
| Jun 30, 2022 | 44.05 Mn |
| Mar 31, 2022 | 30.98 Mn |
| Dec 31, 2021 | 52.69 Mn |
| Sep 30, 2021 | 44.72 Mn |
| Jun 30, 2021 | 40.93 Mn |